Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.810
-0.590 (-10.93%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Radiopharm Theranostics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Radiopharm Theranostics stock has a target of 15, which predicts an increase of 211.85% from the current stock price of 4.81.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Radiopharm Theranostics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 |
---|---|
Strong Buy | 1 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +211.85% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.